Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
6.73M
-
Shares change
-
+10.3K
-
Total reported value, excl. options
-
$108M
-
Value change
-
+$166K
-
Number of buys
-
1
-
Price
-
$16.05
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q4 2023
2 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.73M shares
of 49.9M outstanding shares and own 13.51% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.78M shares), TAKEDA PHARMACEUTICAL CO LTD (6.72M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4M shares), Deep Track Capital, LP (2.9M shares), VR Adviser, LLC (2.08M shares), FRANKLIN RESOURCES INC (1.85M shares), Carlyle Group Inc. (1.84M shares), BlackRock Inc. (1.78M shares), VANGUARD GROUP INC (1.46M shares), and T. Rowe Price Investment Management, Inc. (1.45M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.